Banque Transatlantique’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9M Buy
60,316
+6,135
+11% +$2.95M 0.71% 34
2026
Q1
$26.7M Sell
54,181
-2,101
-4% -$1.14M 0.64% 31
2025
Q4
$32.7M Sell
56,282
-57,066
-50% -$32.3M 0.79% 25
2025
Q3
$55.2M Sell
113,348
-250
-0.2% -$116K 1.35% 18
2025
Q2
$46.4M Sell
113,598
-19,532
-15% -$8.17M 1.28% 18
2025
Q1
$66.1M Sell
133,130
-18,805
-12% -$10.2M 2% 14
2024
Q4
$71M Buy
+151,935
New +$83.5M 1.81% 14

Other funds holding TMO

Banque Transatlantique's TMO Position: Q2 2026 in Review

Banque Transatlantique increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $2.95M and bringing the position to 60,316 shares worth $32.9M. The position accounts for 0.71% of the portfolio, ranked #34.

Banque Transatlantique first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $71M in Q4 2024. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Banque Transatlantique held 60,316 shares of Thermo Fisher Scientific worth $32.9M as of Q2 2026.
  • Banque Transatlantique bought 6,135 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.95M.
  • Thermo Fisher Scientific made up 0.71% of Banque Transatlantique's portfolio in Q2 2026, its #34 holding.
  • Banque Transatlantique first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Thermo Fisher Scientific position peaked at $71M in Q4 2024.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.